<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-85890</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Facial erysipelas</dc:title>
<dc:description xml:lang="en">The erysipelas is an acute bacterial infection that affects to the dermis and, with fewer extension, to the hypodermis and that characteristically extends into the cutaneous lymphatics. Patients typically have an erythematous, warm, indurated and shiny plaque that exhibits well-demarcated advancing margins. Historically, erysipelas occurred on the face and was caused by Streptococcus pyogenes, though a change happens in the location and etiology. The treatment of choice is the penicillin G, which is active in 80% of the cases. It can be administrated on an outpatient basis if the patient is not feverish or with signs of toxemia. We present a case of a 4-year-old girl with atopic dermatitis that presented a facial erysipelas that completely recovered with oral cloxacillin (AU)</dc:description>
<dc:creator>Velázquez Tarjuelo, D</dc:creator>
<dc:creator>Hernanz Hermosa, J. M</dc:creator>
<dc:creator>Mauleón Fernández, C</dc:creator>
<dc:creator>Silvente San Nicasio, C</dc:creator>
<dc:creator>Álvarez Garrido, H</dc:creator>
<dc:creator>Valdivielso Ramos, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La erisipela es una infección aguda bacteriana que afecta a la dermis y, con menos extensión, al tejido celular subcutáneo y que característicamente implica al sistema linfático. Los pacientes presentan típicamente una placa eritematosa, caliente, dura y brillante, con unos márgenes de avance bien delimitados. La localización clásica es la cara y el agente causal el Streptococcus pyogenes, aunque está ocurriendo un cambio en la localización y etiología. El tratamiento de elección es la penicilina G, que es activa en el 80% de los casos y que se puede administrar de forma ambulatoria si el paciente no está febrilo con signos de toxemia. Presentamos el caso de una niña de 4 años con antecedentes de dermatitis atópica que presentó unc uadro de erisipela facial que respondió favorablemente al tratamiento con cloxacilina (AU)</dc:description>
<dc:source>Acta Pediatr Esp;68(10): 509-511, nov. 2010. ilus</dc:source>
<dc:identifier>ibc-85890</dc:identifier>
<dc:title xml:lang="es">Erisipela facial</dc:title>
<dc:subject>^d29622</dc:subject>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d2515^s22016</dc:subject>
<dc:subject>^d10592^s22073</dc:subject>
<dc:subject>^d4972^s22016</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4972^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d4972^s22053</dc:subject>
<dc:subject>^d13684^s22052</dc:subject>
<dc:subject>^d13684^s22011</dc:subject>
<dc:subject>^d13596^s22052</dc:subject>
<dc:subject>^d6344^s22053</dc:subject>
<dc:subject>^d2515^s22012</dc:subject>
<dc:subject>^d2515^s22067</dc:subject>
<dc:subject>^d10592^s22000</dc:subject>
<dc:subject>^d2515^s22053</dc:subject>
<dc:subject>^d6344^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201011</dc:date>
</metadata>
</record>
</ibecs-document>
